483
PRIMROSE CANDY COPRIMROSE CANDY CO – FDA 483, Sep 26, 2017
Record Details
An FDA inspection of Primrose Candy Co, an OTC drug manufacturer in Chicago, revealed significant deficiencies in its quality control and manufacturing processes for menthol lozenges. The firm failed to establish adequate laboratory controls, including proper assay procedures, equipment calibration, and stability testing. Additionally, the company released drug products without proper testing and lacked process validation, indicating a systemic failure to ensure drug product quality.
View Company Profile
ID · c1119e36-6999-49e5-8474-898774449804
Other documents for PRIMROSE CANDY CO
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.